SCHEMBL1737241

SCHEMBL1737241

C=CCC(=O)CCCCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2136226 0.85
SCHEMBL11512909 0.79 MAPT (0.45)
SCHEMBL10373212 0.79 MAPT (0.40)
SCHEMBL3627376 0.79 ALDH1A1 (0.35)
SCHEMBL10374940 0.76
SCHEMBL5363940 0.76
SCHEMBL11870573 0.76 SLC22A6 (0.52)
SCHEMBL9101926 0.76
SCHEMBL7698896 0.76 MAPT (0.58)
SCHEMBL28426128 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111393275-A Method for synthesizing intermediate farnesyl acetone and method for synthesizing phytol, isophytol and geranylgeraniol by using intermediate farnesyl acetone 上海现代哈森(商丘)药业有限公司 2020-07-10 CN claimed
EP-1420021-A1 DNA Methyltransferase inhibitors The Penn State Research Foundation (US) 2004-05-19 EP claimed
JP-2003501431-A 2003-01-14 JP claimed
EP-1181291-A2 DNA METHYLTRANSFERASE INHIBITORS THE PENN STATE RESEARCH FOUNDATION (US) 2002-02-27 EP claimed
WO-2000075142-A2 DNA METHYLTRANSFERASE INHIBITORS THE PENN STATE RESEARCH FOUNDATION (US) 2000-12-14 WO claimed
CN-109689645-B Cyanoindoline derivatives as NIK inhibitors 杨森制药有限公司 2022-06-03 CN disclosed
US-11186589-B2 Cyanoindoline derivatives as NIK inhibitors JANSSEN PHARMACEUTICA NV (BE) 2021-11-30 US disclosed
US-20210032267-A1 CYANOINDOLINE DERIVATIVES AS NIK INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2021-02-04 US disclosed
EP-3478673-B1 CYANOINDOLINE DERIVATIVES AS NIK INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2020-09-16 EP disclosed
CN-111393275-A Method for synthesizing intermediate farnesyl acetone and method for synthesizing phytol, isophytol and geranylgeraniol by using intermediate farnesyl acetone 上海现代哈森(商丘)药业有限公司 2020-07-10 CN disclosed
EP-3478673-A1 CYANOINDOLINE DERIVATIVES AS NIK INHIBITORS Janssen Pharmaceutica N.V. (BE) 2019-05-08 EP disclosed
US-20190119299-A1 CYANOINDOLINE DERIVATIVES AS NIK INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2019-04-25 US disclosed
US-4181665-A INTERMEDIATES FOR AMINO DERIVATIVES POSSESSING HYPOTENSIVE AND CENTRAL NERVOUS SYSTEM ACTIVITY THE UPJOHN COMPANY (US) 1980-01-01 US disclosed
US-4179510-A ISOCHROMANS AND 2-BENZOXEPINS THE UPJOHN COMPANY (US) 1979-12-18 US disclosed
US-4166062-A HYPOTENSIVE AGENTS, CNS, ANTIDEPRESSANTS THE UPJOHN COMPANY (US) 1979-08-28 US disclosed
US-4163053-A Anti-hypertensive 5-[2-(substituted anilinoalkylamino)-1-hydroxyalkyl]salicylamides SCHERING CORPORATION (US) 1979-07-31 US disclosed
EP-0002867-A1 5-(2-Anilinoalkylamino-1-hydroxyalkyl)salicylamides, their preparation and anti-hypertensive compositions containing them Technobiotic Ltd. (CH) 1979-07-11 EP disclosed
US-4158012-A Steroid synthesis process using mixed anhydride SYNTEX (U.S.A.) INC. (US) 1979-06-12 US disclosed
US-4153612-A 2-Benzoxepins THE UPJOHN COMPANY (US) 1979-05-08 US disclosed
US-4018930-A ANALGESICS, SEDATIVES, TRANQUILIZERS ENDO LABORATORIES, INC. (US) 1977-04-19 US disclosed